Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer.

Ryan PD, Goss PE.

Oncologist. 2008 Jan;13(1):16-24. doi: 10.1634/theoncologist.2007-0199. Review.

2.

The therapeutic potential of agents targeting the type I insulin-like growth factor receptor.

Zhang H, Yee D.

Expert Opin Investig Drugs. 2004 Dec;13(12):1569-77. Review.

PMID:
15566314
3.

Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway--therapeutic perspectives in cancer.

Tao Y, Pinzi V, Bourhis J, Deutsch E.

Nat Clin Pract Oncol. 2007 Oct;4(10):591-602. Review.

PMID:
17898809
4.

Treatment of hematologic malignancies and solid tumors by inhibiting IGF receptor signaling.

Mitsiades CS, Mitsiades N.

Expert Rev Anticancer Ther. 2005 Jun;5(3):487-99. Review.

PMID:
16001956
5.

Resistance pathways relevant to insulin-like growth factor-1 receptor-targeted therapy.

Hendrickson AW, Haluska P.

Curr Opin Investig Drugs. 2009 Oct;10(10):1032-40. Review.

PMID:
19777391
6.

Targeting insulin-like growth factor 1 receptor in sarcomas.

Scotlandi K, Picci P.

Curr Opin Oncol. 2008 Jul;20(4):419-27. doi: 10.1097/CCO.0b013e328302edab. Review.

PMID:
18525338
7.

Targeting insulin-like growth factor type 1 receptor in cancer therapy.

Atzori F, Traina TA, Ionta MT, Massidda B.

Target Oncol. 2009 Dec;4(4):255-66. doi: 10.1007/s11523-009-0123-z. Epub 2009 Oct 30. Review.

PMID:
19876700
8.

The insulin-like growth factor 1 receptor in cancer: old focus, new future.

Hartog H, Wesseling J, Boezen HM, van der Graaf WT.

Eur J Cancer. 2007 Sep;43(13):1895-904. Epub 2007 Jul 10. Review.

PMID:
17624760
9.

Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer.

Hofmann F, García-Echeverría C.

Drug Discov Today. 2005 Aug 1;10(15):1041-7. Review.

PMID:
16055020
10.

Insulin and insulin-like growth factor signalling in neoplasia.

Pollak M.

Nat Rev Cancer. 2008 Dec;8(12):915-28. doi: 10.1038/nrc2536. Review. Erratum in: Nat Rev Cancer. 2009 Mar;9(3):224.

PMID:
19029956
11.

Insulin-Like Growth Factor (IGF) family and prostate cancer.

Gennigens C, Menetrier-Caux C, Droz JP.

Crit Rev Oncol Hematol. 2006 May;58(2):124-45. Epub 2006 Jan 18. Review.

PMID:
16387509
12.

The insulin-like growth factor pathway as a target for cancer therapy.

López-Calderero I, Sánchez Chávez E, García-Carbonero R.

Clin Transl Oncol. 2010 May;12(5):326-38. doi: 10.1007/s12094-010-0514-8. Review.

PMID:
20466617
13.

IGF-IR: potential role in antitumor agents.

Guerreiro AS, Boller D, Doepfner KT, Arcaro A.

Drug News Perspect. 2006 Jun;19(5):261-72. Review.

PMID:
16941048
14.

The insulin like growth factor-1 receptor (IGF-1R) as a drug target: novel approaches to cancer therapy.

Bähr C, Groner B.

Growth Horm IGF Res. 2004 Aug;14(4):287-95. Review.

PMID:
15231297
15.

IGF1R signalling and its inhibition.

Riedemann J, Macaulay VM.

Endocr Relat Cancer. 2006 Dec;13 Suppl 1:S33-43. Review.

16.

[Targeting insulin-like growth factors in the treatment of cancer].

Moro-Sibilot D, Coudurier M, Lantuejoul S.

Rev Mal Respir. 2010 Oct;27(8):959-63. doi: 10.1016/j.rmr.2010.07.005. Epub 2010 Sep 17. Review. French.

PMID:
20965410
17.

Clinical development of inhibitors of the insulin-like growth factor receptor in oncology.

Gualberto A, Pollak M.

Curr Drug Targets. 2009 Oct;10(10):923-36. Review.

PMID:
19663769
18.

Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy.

van der Veeken J, Oliveira S, Schiffelers RM, Storm G, van Bergen En Henegouwen PM, Roovers RC.

Curr Cancer Drug Targets. 2009 Sep;9(6):748-60. Review.

PMID:
19754359
19.

Targeting the insulin-like growth factor receptor-1R pathway for cancer therapy.

Zha J, Lackner MR.

Clin Cancer Res. 2010 May 1;16(9):2512-7. doi: 10.1158/1078-0432.CCR-09-2232. Epub 2010 Apr 13.

20.

[Research progress on the relationship between insulin-like growth factor-I and lung cancer].

Liu Z, Yue W, Li Q.

Zhongguo Fei Ai Za Zhi. 2010 Jun;13(6):642-7. doi: 10.3779/j.issn.1009-3419.2010.06.014. Review. Chinese. No abstract available.

Supplemental Content

Support Center